Study of JK06 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called JK06 for people with advanced solid tumors that cannot be removed by surgery or have spread. It aims to see if JK06 is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have advanced solid tumors that cannot be removed by surgery or have spread to other parts of the body
- You are willing to provide a tumor sample (either from a previous biopsy or a new one)
- You have adequate organ function, such as blood counts and liver/kidney tests within certain limits
- You are in generally good health, able to care for yourself (ECOG score 0 or 1)
- You agree to use effective contraception if you or your partner can become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called JSKN027 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this drug is safe and if it can shrink tumors or slow their growth.
This trial tests a new drug, JSKN016HC, in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can help shrink or control the tumor.
This trial tests a new drug, JSKN022, for people with advanced solid tumors that have stopped responding to standard treatments or are not eligible for them. The goal is to see if the drug is safe and effective.
This trial tests a new drug called JSKN033 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug, JSKN021, for people with advanced solid tumors that have not responded to standard treatments, are not tolerated to them, or have no standard options. The goal is to see if the drug is safe and effective in treating these cancers.
This trial tests an experimental drug called KM602 for people with advanced solid tumors that have stopped responding to standard treatments, particularly melanoma and non-small cell lung cancer. It aims to see if the drug is safe and effective in shrinking or controlling tumors.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.